ATE244011T1 - Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin - Google Patents

Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin

Info

Publication number
ATE244011T1
ATE244011T1 AT92912205T AT92912205T ATE244011T1 AT E244011 T1 ATE244011 T1 AT E244011T1 AT 92912205 T AT92912205 T AT 92912205T AT 92912205 T AT92912205 T AT 92912205T AT E244011 T1 ATE244011 T1 AT E244011T1
Authority
AT
Austria
Prior art keywords
suppression
aspirin
thromboxic
percutane
administration
Prior art date
Application number
AT92912205T
Other languages
English (en)
Inventor
Rudolph M Keimowitz
Desmond J Fitzgerald
Original Assignee
Keimowitz Rudolph M D
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keimowitz Rudolph M D, Univ Vanderbilt filed Critical Keimowitz Rudolph M D
Application granted granted Critical
Publication of ATE244011T1 publication Critical patent/ATE244011T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
AT92912205T 1991-04-03 1992-04-02 Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin ATE244011T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68019591A 1991-04-03 1991-04-03
PCT/US1992/002576 WO1992020343A1 (en) 1991-04-03 1992-04-02 Suppression of thromboxane levels by percutaneous administration of aspirin

Publications (1)

Publication Number Publication Date
ATE244011T1 true ATE244011T1 (de) 2003-07-15

Family

ID=24730117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912205T ATE244011T1 (de) 1991-04-03 1992-04-02 Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin

Country Status (12)

Country Link
EP (1) EP0578780B1 (de)
JP (1) JPH06510984A (de)
KR (1) KR100247441B1 (de)
AT (1) ATE244011T1 (de)
AU (1) AU668352B2 (de)
CA (1) CA2107587C (de)
DE (1) DE69233116T2 (de)
DK (1) DK0578780T3 (de)
FI (1) FI934324A0 (de)
NO (1) NO306536B1 (de)
WO (1) WO1992020343A1 (de)
ZA (1) ZA922464B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy
WO1994013302A1 (de) * 1991-12-20 1994-06-23 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
DE19616539A1 (de) * 1996-04-25 1997-11-06 Luitpold Pharma Gmbh Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
JP2000351729A (ja) * 1999-06-08 2000-12-19 Shionogi & Co Ltd トロンボキサンa2受容体拮抗剤の経皮吸収製剤
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
WO2002085376A2 (en) * 2001-04-19 2002-10-31 Universite De Montreal A method for decreasing superoxide anion production and for the treatment of diseases associated with oxidative stress
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2295753A1 (fr) * 1974-12-23 1976-07-23 Despin Jean Composition a base d'acide acetyl-salicylique a usage topique
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
DE3583698D1 (de) * 1984-04-23 1991-09-12 Kao Corp Perkutaner absorptions-beschleuniger und diesen enthaltendes praeparat.
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin

Also Published As

Publication number Publication date
KR100247441B1 (ko) 2000-04-01
NO306536B1 (no) 1999-11-22
NO933529L (no) 1993-11-29
WO1992020343A1 (en) 1992-11-26
DE69233116D1 (de) 2003-08-07
DK0578780T3 (da) 2003-08-18
JPH06510984A (ja) 1994-12-08
AU668352B2 (en) 1996-05-02
NO933529D0 (no) 1993-10-01
CA2107587A1 (en) 1992-10-04
DE69233116T2 (de) 2004-08-26
CA2107587C (en) 2004-11-23
FI934324A0 (fi) 1993-10-01
EP0578780A1 (de) 1994-01-19
AU2014292A (en) 1992-12-30
EP0578780B1 (de) 2003-07-02
ZA922464B (en) 1992-12-30

Similar Documents

Publication Publication Date Title
DE3583008D1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
DK0494972T3 (da) Brusedosisform samt fremgangsmåde til administration heraf
FI960102A0 (fi) Uusi farmaseuttinen seos
ES2084944T3 (es) Amidas terapeuticas.
FI854128A0 (fi) Foerfarande foer framstaellning av en foedoaemneskomposition som innehaoller inosotoltrifosfat och denna komposition.
IT8720698A0 (it) Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer.
DK0395329T3 (da) Sammensætning i form af et skum indeholdende 5-aminosalicylsyre til intrarektal administration
CS195285A3 (en) Pyridazine derivatives substituted by cyclic amines and process forpreparing thereof
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
ATE244011T1 (de) Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
ES2181849T3 (es) Procedimiento para minimizar la perdida osea.
DE3866045D1 (de) Arzneimittel zur behandlung von uraemie.
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
JPS5785370A (en) Antiallergic imidodisulfamides, manufacture and medicinal composition containing same
FI884960A0 (fi) Anvaendning av 2-pyrimidinyl-1-piperazin-derivat.
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
DK0443957T3 (da) Hidtil ukendte steroid-forbindelser med en spirogruppe i position 17, en fremgangsmåde og mellemprodukter til fremstilling deraf, deres anvendelse som lægemiddel og farmaceutiske præparater med indhold deraf
DE69233315D1 (de) Pharmazeutische lysin enthaltende polypeptid-zusammensetzungen und verfahren zu deren verwendung
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
IL96161A0 (en) Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties